Sections
Shows
Events
High immune response to COVID variants in breakthrough cases after two Covaxin jabs: ICMR study
Interim analysis of phase-3 trials of COVAXIN shows 78% clinical efficacy, claims Bharat Biotech
Two tested positive for swine flu in Manipur during coronavirus screening; one of the affected had visited China recently
